These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2439018)

  • 1. [Antitumor effects and pulmonary toxicity of bleomycin administered by continuous subcutaneous infusion in patients with advanced cervical cancer].
    Miyamoto T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1830-5. PubMed ID: 2439018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous subcutaneous infusion of peplomycin in oral squamous carcinoma].
    Kanazawa H; Takahashi K; Hanazawa Y; Uchiyama S; Takahara T; Takahara M; Muto M; Kinehara M; Sato K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):775-80. PubMed ID: 2469396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effect of combination chemotherapy with peplomycin and mitomycin C (PM therapy) in recurrent uterine cervical cancer].
    Yokoyama T; Hiura M; Kaneko H; Yorishima M; Tanaka M; Chiba T
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):73-8. PubMed ID: 2447837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential combination of bleomycin and mitomycin in advanced cervical cancer--an American experience: a Northern California Oncology Group study.
    Greenberg BR; Hannigan J; Gerretson L; Turbow MM; Friedman MA; Hendrickson CA; Glassberg A; Carter SK
    Cancer Treat Rep; 1982 Jan; 66(1):163-5. PubMed ID: 6171349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinoma.
    Wheeler RH; Liepman MK; Baker SR; Earhart RH; Bull FE; Ensminger WD
    Cancer Treat Rep; 1980; 64(8-9):943-9. PubMed ID: 6160914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancer.
    Baker LH; Opipari MI; Wilson H; Bottomley R; Coltman CA
    Obstet Gynecol; 1978 Aug; 52(2):146-50. PubMed ID: 79991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of the pulmonary toxicity of continuously infused bleomycin.
    Cooper KR; Hong WK
    Cancer Treat Rep; 1981; 65(5-6):419-25. PubMed ID: 6165471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z; Koketsu H; Nakajima T; Niitani H
    Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic and therapeutic studies of the administration of peplomycin by continuous subcutaneous infusion].
    Yasui Y; Suzumori K; Yagami Y
    Gan No Rinsho; 1988 Nov; 34(14):1975-8. PubMed ID: 2462650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved therapeutic index of bleomycin when administered by continuous infusion in mice.
    Sikic BI; Collins JM; Mimnaugh EG; Gram TE
    Cancer Treat Rep; 1978 Dec; 62(12):2011-7. PubMed ID: 87269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent pelvic infusion with vincristine, bleomycin, and mitomycin C for advanced recurrent carcinoma of the cervix.
    Swenerton KD; Evers JA; White GW; Boyes DA
    Cancer Treat Rep; 1979 Aug; 63(8):1379-81. PubMed ID: 89908
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix.
    Alberts DS; Martimbeau PW; Surwit EA; Oishi N
    Cancer Clin Trials; 1981; 4(3):313-6. PubMed ID: 6169465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of squamous cell carcinomas with prolonged, continuous infusions of bleomycin and cisplatinum. A first series of 80 cases with 75% objective response (author's transl)].
    Israël L; Aguilera J; Breau JL
    Nouv Presse Med; 1981 May; 10(22):1817-8, 1823-4. PubMed ID: 6164978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of bronchial artery infusion (B-AI) with single use of MMC after intravenous peplomycin (PEP) administration in lung cancer].
    Yokoyama K; Takashima T; Nozaki M; Kurokawa A; Matsumoto K
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):265-9. PubMed ID: 2578769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
    Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
    Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot study.
    Leichman LP; Baker LH; Stanhope CR; Samson MK; Fraile RJ; Vaitkevicius VK; Hilgers R
    Cancer Treat Rep; 1980; 64(10-11):1139-40. PubMed ID: 6161699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
    Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.